AtriCure logo

AtriCure

ATRC | NASDAQ
Chart Builder DCF Calculator
$55.31
-$1.53 (-2.69%)
At close: Nov 16, 2026, 4:00 PM ET
$55.31
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-2.69%

Rating

Updated: Nov 16, 2026
55.9
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #171/1021 (Top 17%)

Key Statistics

Market Data

Market Cap $2.82B
1D Range
55.02 57.54
52W Range
25.86 65.53

Valuation (TTM)

PE 184.37
PB 5.28
EV/EBITDA 79.85

Valuation (NTM)

Forward PE 247.13
Forward PEG -1.15
Price Target $64.00
Loading financial charts...

Profile

AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves. Its market reach spans the United States, Europe, Asia, and other int...

Sector Healthcare
Employees 1,350
IPO Date Aug 5, 2005
Fiscal Year January - December

Latest News

AtriCure, Inc. (ATRC) Presents at 2026 UBS Global Healthcare Conference Transcript

8 days ago · seekingalpha.com

AtriCure, Inc. (ATRC) Presents at 2026 UBS Global Healthcare Conference Transcript
AtriCure: A New Quality Metric Could Put A Clip In Nearly Every Sternotomy

9 days ago · seekingalpha.com

AtriCure: A New Quality Metric Could Put A Clip In Nearly Every Sternotomy
AtriCure Analysts Boost Their Forecasts After Better-Than-Expected Q3 Results

13 days ago · benzinga.com

AtriCure Analysts Boost Their Forecasts After Better-Than-Expected Q3 Results
AtriCure, Inc. (ATRC) Q3 2026 Earnings Call Transcript

13 days ago · seekingalpha.com

AtriCure, Inc. (ATRC) Q3 2026 Earnings Call Transcript
What AtriCure (ATRC) Said on Its Q3 Earnings Call

13 days ago · marketbeat.com

What AtriCure (ATRC) Said on Its Q3 Earnings Call
Compared to Estimates, AtriCure (ATRC) Q3 Earnings: A Look at Key Metrics

13 days ago · zacks.com

Compared to Estimates, AtriCure (ATRC) Q3 Earnings: A Look at Key Metrics
AtriCure (ATRC) Beats Q3 Earnings and Revenue Estimates

13 days ago · zacks.com

AtriCure (ATRC) Beats Q3 Earnings and Revenue Estimates
AtriCure to Announce Third Quarter 2026 Financial Results

1 month ago · businesswire.com

AtriCure to Announce Third Quarter 2026 Financial Results
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?

2 months ago · zacks.com

Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?
Do Options Traders Know Something About AtriCure Stock We Don't?

2 months ago · zacks.com

Do Options Traders Know Something About AtriCure Stock We Don't?

Earnings

Latest Earnings
Nov 3, 2026
EPS
$0.17
Beat +407.97%
REV
$154.45M
Beat +2.25%
Next Earnings
Feb 16, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
9
Consensus
Buy
Price Target
$64.00
Upside
+15.71%
Buy (6)
Hold (3)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.